Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 21.37
-0.01 (-0.05%)
Feb 4, 2026, 2:45 PM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 8.27 billion as of February 3, 2026. Its market cap has decreased by -4.87% in one year.
Market Cap
8.27B
Enterprise Value
7.06B
Revenue
1.13B
Ranking
n/a
PE Ratio
28.97
Stock Price
21.37
Market Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 8.27B, an increase of 417.98%. That is a compound annual growth rate of 21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 8.27B | 4.50% |
| Dec 31, 2025 | 7.92B | -11.84% |
| Dec 31, 2024 | 8.98B | 3.50% |
| Dec 29, 2023 | 8.67B | -17.63% |
| Dec 30, 2022 | 10.53B | -37.10% |
| Dec 31, 2021 | 16.74B | -3.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Kingmed Diagnostics Group | 14.32B |
| Dian Diagnostics Group | 14.17B |
| Shanghai Runda Medical Technology | 9.31B |
| Beijing Strong Biotechnologies,Inc. | 7.60B |
| Maccura Biotechnology Co.Ltd | 7.21B |
| Cowealth Medical China | 6.98B |
| SMO ClinPlus CO.,LTD. | 5.42B |
| Guangdong Hybribio Biotech | 4.52B |